Bionano Genomics Reports Q4 and Full-Year 2025 Results, Sees Continued Growth in OGM Utilization

Bionano Genomics reported Q4 2025 total revenue of $8.0 million, a 3% decrease from the same period in 2024. Consumables and software revenues decreased 1%, while gross margin increased to 43%. For the full year, total revenue decreased 7% to $28.5 million, with consumables and software revenues increasing 7%. The company reduced operating expenses by 22% and installed 9 new OGM systems, bringing its installed base to 387.